Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
47,601,550
-
Total 13F shares
-
23,117,706
-
Share change
-
+2,224,201
-
Total reported value
-
$274,324,124
-
Price per share
-
$11.93
-
Number of holders
-
38
-
Value change
-
+$29,029,648
-
Number of buys
-
18
-
Number of sells
-
11
Institutional Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q4 2020
As of 31 Dec 2020,
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,117,706 shares.
The largest 10 holders included
BVF INC/IL, Blackstone Group Inc., Avidity Partners Management LP, Soleus Capital Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, Vivo Capital, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Omega Fund Management, LLC, Logos Global Management LP, and JANUS HENDERSON GROUP PLC.
This page lists
38
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.